- Home
- EXAS vs BROS Comparison
EXAS vs BROS Comparison
Compare EXAS & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- BROS
- Stock Information
- Founded
- EXAS 1995
- BROS 1992
- Country
- EXAS United States
- BROS United States
- Employees
- EXAS N/A
- BROS N/A
- Industry
- EXAS Medical Specialities
- BROS Restaurants
- Sector
- EXAS Health Care
- BROS Consumer Discretionary
- Exchange
- EXAS Nasdaq
- BROS Nasdaq
- Market Cap
- EXAS 10.7B
- BROS 9.4B
- IPO Year
- EXAS N/A
- BROS 2021
- Fundamental
- Price
- EXAS $56.13
- BROS $71.76
- Analyst Decision
- EXAS Strong Buy
- BROS Strong Buy
- Analyst Count
- EXAS 20
- BROS 15
- Target Price
- EXAS $70.68
- BROS $78.27
- AVG Volume (30 Days)
- EXAS 3.3M
- BROS 3.4M
- Earning Date
- EXAS 07-30-2025
- BROS 05-07-2025
- Dividend Yield
- EXAS N/A
- BROS N/A
- EPS Growth
- EXAS N/A
- BROS 109.32
- EPS
- EXAS N/A
- BROS 0.38
- Revenue
- EXAS $2,828,128,000.00
- BROS $1,361,068,000.00
- Revenue This Year
- EXAS $14.58
- BROS $26.31
- Revenue Next Year
- EXAS $12.75
- BROS $23.86
- P/E Ratio
- EXAS N/A
- BROS $186.29
- Revenue Growth
- EXAS 11.57
- BROS 30.42
- 52 Week Low
- EXAS $39.97
- BROS $26.96
- 52 Week High
- EXAS $72.83
- BROS $86.88
- Technical
- Relative Strength Index (RSI)
- EXAS 60.75
- BROS 59.92
- Support Level
- EXAS $55.26
- BROS $69.32
- Resistance Level
- EXAS $58.68
- BROS $72.67
- Average True Range (ATR)
- EXAS 1.99
- BROS 2.66
- MACD
- EXAS -0.27
- BROS 0.15
- Stochastic Oscillator
- EXAS 62.66
- BROS 76.72
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.